Terms: = Thyroid cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Diagnosis
98 results:
1.
Sfreddo HJ; Koh ES; Zhao K; Swartzwelder CE; Untch BR; Marti JL; Roman BR; Dublin J; Wang RS; Xia R; Cohen JM; Xu B; Ghossein R; Givi B; Boyle JO; Tuttle RM; Fagin JA; Wong RJ; Morris LGT
Thyroid; 2024 Apr; 34(4):450-459. PubMed ID: 38407967
[No Abstract] [Full Text] [Related]
2. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
3. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
4. A mutation panel comprising BRAF
Eng ZH; Ahmad Jefry MM; Ng KL; Abdul Aziz A; Mat Junit S
Malays J Pathol; 2023 Dec; 45(3):375-390. PubMed ID: 38155379
[TBL] [Abstract] [Full Text] [Related]
5. Fine-needle biopsy of thyroid nodules and the contribution of molecular analysis of BRAF and RAS mutations.
Kasko M; Grigerova M; Alemayehu A; Zavodna K; Kasko V; Podoba J
Bratisl Lek Listy; 2023; 124(12):869-872. PubMed ID: 37983279
[TBL] [Abstract] [Full Text] [Related]
6. Macrofollicular Architecture in Invasive Encapsulated Follicular Variant of Papillary thyroid Carcinoma: A Pitfall in thyroid Practice.
Yadav S; Kandasamy D; Damle N; Goel R; Chumber S; Sharma MC; Boruah M; Agarwal S
Head Neck Pathol; 2023 Dec; 17(4):899-909. PubMed ID: 37775618
[TBL] [Abstract] [Full Text] [Related]
7. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification.
Zhou Y; Wu X; Zhang Y; Li Z; Ge X; Chen H; Mao Y; Ding W
PeerJ; 2023; 11():e16054. PubMed ID: 37744220
[TBL] [Abstract] [Full Text] [Related]
8.
Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
[TBL] [Abstract] [Full Text] [Related]
9. Brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion.
Gubbiotti MA; Livolsi V
Clin Neurol Neurosurg; 2023 Apr; 227():107639. PubMed ID: 36889238
[TBL] [Abstract] [Full Text] [Related]
10. Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study.
Tang J; Ma J; Xi X; Wang L; Li H; Huo S; Zhang B
Endocrine; 2023 Jun; 80(3):552-562. PubMed ID: 36542267
[TBL] [Abstract] [Full Text] [Related]
11. [Diagnostic values of cyclin D1 immunocytochemistry and molecular testing in preoperative fine needle aspiration of undeterminate thyroid nodules].
He SR; Zhang JX; Chen RM; Hu ST; Yang L; Chen L; Zhang Z; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1210-1216. PubMed ID: 36480828
[No Abstract] [Full Text] [Related]
12. thyroid carcinoma metastases to central nervous system and vertebrae.
Kleinschmidt-DeMasters B; Marshall C
Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of a pre-2017 follicular variant papillary thyroid carcinoma cohort reclassified as noninvasive follicular thyroid neoplasm with papillary-like features (NIFTP): an 11-year retrospective single institution experience.
Beg S; Khan SI; Cui I; Scognamiglio T; Rao R
J Am Soc Cytopathol; 2023; 12(2):112-119. PubMed ID: 36372672
[TBL] [Abstract] [Full Text] [Related]
14. thyroid Oncocytic (Hürthle Cell) Nodules With Longitudinal Nuclear Grooves: Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 15 Cases.
Suster D; Mackinnon AC; Suster S
Arch Pathol Lab Med; 2023 Jun; 147(6):684-691. PubMed ID: 36084253
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic features of thyroid nodules with PTEN mutations on preoperative testing.
Quaytman JA; Nikiforov YE; Nikiforova MN; Morariu E
Endocr Relat Cancer; 2022 Sep; 29(9):513-520. PubMed ID: 35723418
[TBL] [Abstract] [Full Text] [Related]
16. Bilateral follicular variant of papillary thyroid cancer with different RAS mutations detected with next-generation sequencing: Report of an unusual case and literature review.
Marín F; Del Nuevo E; Belinchón A; Acevedo A
Diagn Cytopathol; 2022 Oct; 50(10):E275-E279. PubMed ID: 35716104
[TBL] [Abstract] [Full Text] [Related]
17. Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
Newfield RS; Jiang W; Sugganth DX; Hantash FM; Lee E; Newbury RO
Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111121. PubMed ID: 35397361
[TBL] [Abstract] [Full Text] [Related]
18. Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric thyroid cancers.
Franco AT; Ricarte-Filho JC; Isaza A; Jones Z; Jain N; Mostoufi-Moab S; Surrey L; Laetsch TW; Li MM; DeHart JC; Reichenberger E; Taylor D; Kazahaya K; Adzick NS; Bauer AJ
J Clin Oncol; 2022 Apr; 40(10):1081-1090. PubMed ID: 35015563
[TBL] [Abstract] [Full Text] [Related]
19. RAS mutation and associated risk of malignancy in the thyroid gland: An FNA study with cytology-histology correlation.
Gilani SM; Abi-Raad R; Garritano J; Cai G; Prasad ML; Adeniran AJ
Cancer Cytopathol; 2022 Apr; 130(4):284-293. PubMed ID: 34847284
[TBL] [Abstract] [Full Text] [Related]
20. Association of Bethesda category and molecular mutation in patients undergoing thyroidectomy.
Mascarella MA; Peeva M; Forest VI; Pusztaszeri MP; Avior G; Tamilia M; Mlynarek AM; Hier MP; Payne RJ
Clin Otolaryngol; 2022 Jan; 47(1):75-80. PubMed ID: 34510770
[TBL] [Abstract] [Full Text] [Related]
[Next]
